Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Total Non-Current Liabilities (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $28.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 54.92% year-over-year to $28.7 million, compared with a TTM value of $28.7 million through Sep 2025, up 54.92%, and an annual FY2024 reading of $9.9 million, down 56.22% over the prior year.
  • Total Non-Current Liabilities was $28.7 million for Q3 2025 at SBC Medical Group Holdings, up from $10.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $28.7 million in Q3 2025 and bottomed at $9.8 million in Q1 2025.
  • Average Total Non-Current Liabilities over 3 years is $16.6 million, with a median of $14.3 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities tumbled 56.22% in 2024, then skyrocketed 54.92% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $22.5 million in 2023, then crashed by 56.22% to $9.9 million in 2024, then skyrocketed by 191.0% to $28.7 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for SBC at $28.7 million in Q3 2025, $10.0 million in Q2 2025, and $9.8 million in Q1 2025.